Видео ютуба по тегу Tp53-Mutant

TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles
TP53-Mutant AML: A Pathology-Guided Journey Through Diagnostic Principles
p53: Guardian of the Genome
p53: Guardian of the Genome
Роль p53 в развитии рака
Роль p53 в развитии рака
Outcomes of TP53-mutant AML with venetoclax and decitabine
Outcomes of TP53-mutant AML with venetoclax and decitabine
TP53-mutant AML linked to poorer outcomes with decitabine plus venetoclax
TP53-mutant AML linked to poorer outcomes with decitabine plus venetoclax
Characterizing TP53 Y220C mutations across solid tumors
Characterizing TP53 Y220C mutations across solid tumors
Novel strategies to target P53-mutant hematological malignancies
Novel strategies to target P53-mutant hematological malignancies
Magrolimab + azacitidine in TP53-mutant AML
Magrolimab + azacitidine in TP53-mutant AML
David Sallman, MD: HCT outcomes & HMA maintenance in TP53-mutant MDS/AML
David Sallman, MD: HCT outcomes & HMA maintenance in TP53-mutant MDS/AML
A Drug to Finally Benefit Patients with TP53 Mutant AML? | David Sallman | ASH 2021 #AML
A Drug to Finally Benefit Patients with TP53 Mutant AML? | David Sallman | ASH 2021 #AML
Choice of HMA for newly diagnosed TP53-mutant AML: a COMMAND registry study
Choice of HMA for newly diagnosed TP53-mutant AML: a COMMAND registry study
How could new treatment combinations improve outcomes in TP53 mutant AML?
How could new treatment combinations improve outcomes in TP53 mutant AML?
Everolimus Inhibits Angiogenesis, Lymphangiogenesis in TP53 Mutant HNSCC | Oncotarget
Everolimus Inhibits Angiogenesis, Lymphangiogenesis in TP53 Mutant HNSCC | Oncotarget
Residual mutant p53 activity linked to cancer survival in males
Residual mutant p53 activity linked to cancer survival in males
APR-246 combination treatments in TP53-mutant R/R NHLs
APR-246 combination treatments in TP53-mutant R/R NHLs
Phase 1B/2 Results for TP53-Mutant MDS and AML
Phase 1B/2 Results for TP53-Mutant MDS and AML
Options available to patients with TP53-mutated MDS beyond stem cell transplantation
Options available to patients with TP53-mutated MDS beyond stem cell transplantation
Impact of allelic state on OS in TP53-mutant AML and HR-MDS
Impact of allelic state on OS in TP53-mutant AML and HR-MDS
Tip-9; P53 immunostain interpretation
Tip-9; P53 immunostain interpretation
Treating TP53 mutant mantle cell lymphoma in the BOVen trial
Treating TP53 mutant mantle cell lymphoma in the BOVen trial
How p53 Protects Your DNA… Until It Turns Against You!
How p53 Protects Your DNA… Until It Turns Against You!